300298.SZ SHZ
Sinocare Inc.
1W: -0.2%
1M: +2.1%
3M: +10.9%
YTD: -9.7%
1Y: -21.9%
3Y: -27.7%
5Y: -44.6%
¥16.30 ($2.43)
+0.20 (+1.24%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$4.4B
+9.5% ▲
5Y CAGR: +20.1%
Gross Profit
$2.4B
+12.4% ▲
5Y CAGR: +16.0%
Operating Income
$399M
+45.1% ▲
5Y CAGR: +7.8%
Net Income
$326M
+14.7% ▲
5Y CAGR: +5.4%
EPS (Diluted)
$0.59
+15.7% ▲
5Y CAGR: +5.6%
EBITDA
$621M
+3.7% ▲
5Y CAGR: +8.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $2.0B | $2.4B | $4.0B | $4.1B | $4.4B |
| YoY Growth | +13.3% | +17.2% | +67.4% | +2.7% | +9.5% |
| Cost of Revenue | $715M | $975M | $1.9B | $1.9B | $2.0B |
| Gross Profit | $1.3B | $1.4B | $2.1B | $2.1B | $2.4B |
| Gross Margin | 64.5% | 58.7% | 52.0% | 53.0% | 54.4% |
| R&D Expenses | $182M | $182M | $306M | $356M | $375M |
| SG&A Expenses | $731M | $900M | $1.3B | $1.4B | $1.6B |
| Operating Expenses | $1.1B | $1.2B | $1.7B | $1.9B | $2.0B |
| Operating Income | $236M | $139M | $376M | $275M | $399M |
| Operating Margin | 11.7% | 5.9% | 9.5% | 6.8% | 9.0% |
| Interest Expense | $19M | $34M | $72M | $66M | $53M |
| Income Before Tax | $248M | $138M | $539M | $249M | $395M |
| Tax Expense | $61M | $31M | $48M | $53M | $49M |
| Net Income | $187M | $108M | $447M | $284M | $326M |
| Net Margin | 9.3% | 4.6% | 11.3% | 7.0% | 7.3% |
| EPS (Diluted) | $0.34 | $0.19 | $0.80 | $0.51 | $0.59 |
| EBITDA | $441M | $354M | $584M | $599M | $621M |
| Shares Outstanding | 558M | 561M | 558M | 557M | 554M |